SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 104.55-0.8%9:36 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lighthouse who wrote (1831)10/27/2001 10:56:08 PM
From: smh  Read Replies (1) of 3202
 
<Should make for some better questions on the conference call today>

Wish someone would have asked about the following from the 2/1/01 CC. "a few partners have told them to expect that they may be entering clinical trials in 2001, triggering royalty payments" The dollars are insignificant, but its the tip of the iceberg.

<Getting out of microarrays (except for royalty agrements with others), public domain clones, transgenics, contract sequencing, and internal SNP work makes sense to me. No dominant positions, no near term profits, no long term revenue streams generated and management time and expense to supervise.>

They claimed that the SNP program was very successful and that they had already achieved just about all that they could in terms of enhancing the existing IP. As for the rest of it, the fact that they are simply shutting down - not selling - the other businesses says it all.

<Focus is clearly on partnerships (Medarex) and IP. To me it looks like INCY is trimming down in order to spend more on the Medarex type deals. Will they cut a deal with ABGX as well or stick solely to MEDX? How many more DNA licensing agreements are in the wings? >

Yes...presumably we will turn profitable in 2002, but will it be a short lived situation?

Regards
SMH
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News